BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 7896882)

  • 1. Expression of the mad gene during cell differentiation in vivo and its inhibition of cell growth in vitro.
    Västrik I; Kaipainen A; Penttilä TL; Lymboussakis A; Alitalo R; Parvinen M; Alitalo K
    J Cell Biol; 1995 Mar; 128(6):1197-208. PubMed ID: 7896882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential expression of the MAD family of transcriptional repressors during differentiation and development.
    Quéva C; Hurlin PJ; Foley KP; Eisenman RN
    Oncogene; 1998 Feb; 16(8):967-77. PubMed ID: 9519870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of Myc and Mad during epidermal differentiation and HPV-associated tumorigenesis.
    Hurlin PJ; Foley KP; Ayer DE; Eisenman RN; Hanahan D; Arbeit JM
    Oncogene; 1995 Dec; 11(12):2487-501. PubMed ID: 8545105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Mad, an antagonist of Myc oncoprotein function, in differentiating keratinocytes during tumorigenesis of the skin.
    Lymboussaki A; Kaipainen A; Hatva E; Västrik I; Jeskanen L; Jalkanen M; Werner S; Stenbäck F; Alitalo R
    Br J Cancer; 1996 Jun; 73(11):1347-55. PubMed ID: 8645578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrasting roles for Myc and Mad proteins in cellular growth and differentiation.
    Chin L; Schreiber-Agus N; Pellicer I; Chen K; Lee HW; Dudast M; Cordon-Cardo C; DePinho RA
    Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8488-92. PubMed ID: 7667316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation.
    Ayer DE; Eisenman RN
    Genes Dev; 1993 Nov; 7(11):2110-9. PubMed ID: 8224841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of myc-max-mad gene expression during hepatocyte proliferation in vivo: Differential regulation of mad family and stress-mediated induction of c-myc.
    Mauleon I; Lombard MN; Muñoz-Alonso MJ; Cañelles M; Leon J
    Mol Carcinog; 2004 Feb; 39(2):85-90. PubMed ID: 14750213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Myc/Max/Mad network members in adipogenesis: inhibition of the proliferative burst and differentiation by ectopically expressed Mad1.
    Pulverer B; Sommer A; McArthur GA; Eisenman RN; Lüscher B
    J Cell Physiol; 2000 Jun; 183(3):399-410. PubMed ID: 10797315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myc and Mad bHLHZ domains possess identical DNA-binding specificities but only partially overlapping functions in vivo.
    James L; Eisenman RN
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10429-34. PubMed ID: 12149476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The C. elegans MDL-1 and MXL-1 proteins can functionally substitute for vertebrate MAD and MAX.
    Yuan J; Tirabassi RS; Bush AB; Cole MD
    Oncogene; 1998 Sep; 17(9):1109-18. PubMed ID: 9764821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of Myc, but not E1a, transformation activity by Max-associated proteins, Mad and Mxi1.
    Lahoz EG; Xu L; Schreiber-Agus N; DePinho RA
    Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5503-7. PubMed ID: 8202517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects by Mad and Max on transformation by cellular and viral oncoproteins.
    Cerni C; Bousset K; Seelos C; Burkhardt H; Henriksson M; Lüscher B
    Oncogene; 1995 Aug; 11(3):587-96. PubMed ID: 7630643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
    Gupta K; Anand G; Yin X; Grove L; Prochownik EV
    Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of Max and role of c-Myc during erythroid and myelomonocytic differentiation of K562 cells.
    Delgado MD; Lerga A; Cañelles M; Gómez-Casares MT; León J
    Oncogene; 1995 Apr; 10(8):1659-65. PubMed ID: 7731722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and properties of a Myc derivative that efficiently homodimerizes.
    Soucek L; Helmer-Citterich M; Sacco A; Jucker R; Cesareni G; Nasi S
    Oncogene; 1998 Nov; 17(19):2463-72. PubMed ID: 9824157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repression of Myc-Ras cotransformation by Mad is mediated by multiple protein-protein interactions.
    Koskinen PJ; Ayer DE; Eisenman RN
    Cell Growth Differ; 1995 Jun; 6(6):623-9. PubMed ID: 7669717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolutionary relationships and functional conservation among vertebrate Max-associated proteins: the zebra fish homolog of Mxi1.
    Schreiber-Agus N; Chin L; Chen K; Torres R; Thomson CT; Sacchettini JC; DePinho RA
    Oncogene; 1994 Nov; 9(11):3167-77. PubMed ID: 7936639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repression of in vivo growth of Myc/Ras transformed tumor cells by Mad1.
    Cerni C; Skrzypek B; Popov N; Sasgary S; Schmidt G; Larsson LG; Lüscher B; Henriksson M
    Oncogene; 2002 Jan; 21(3):447-59. PubMed ID: 11821957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of E-box DNA binding during myeloid differentiation reveals complexes that contain Mad but not Max.
    Ryan KM; Birnie GD
    Biochem J; 1997 Jul; 325 ( Pt 1)(Pt 1):79-85. PubMed ID: 9224632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two MAD tails: what the recent knockouts of Mad1 and Mxi1 tell us about the MYC/MAX/MAD network.
    Foley KP; Eisenman RN
    Biochim Biophys Acta; 1999 May; 1423(3):M37-47. PubMed ID: 10382539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.